{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:08:01Z","timestamp":1790845681466,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.radonc.2018.03.030","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T23:27:54Z","timestamp":1524785274000},"page":"304-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases"],"prefix":"10.1016","volume":"127","author":[{"given":"Darby","family":"Erler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Brotherston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Sahgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Loblaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2018.03.030_b0005","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.clon.2011.11.004","article-title":"Update on the systematic review of palliative radiotherapy trials for bone metastases","volume":"24","author":"Chow","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2018.03.030_b0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.clon.2012.04.006","article-title":"The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy","volume":"24","author":"Sahgal","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2018.03.030_b0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.radonc.2010.01.025","article-title":"A comparison of two immobilization systems for stereotactic body radiation therapy of lung tumors","volume":"95","author":"Han","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.03.030_b0020","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.1016\/j.ijrobp.2011.06.1980","article-title":"Spine stereotactic body radiotherapy utilizing cone-beam CT image-guidance with a robotic couch: intrafraction motion analysis accounting for all six degrees of freedom","volume":"82","author":"Hyde","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.03.030_b0025","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/sim.4780120803","article-title":"Kaplan\u2013Meier, marginal or conditional probability curves in summarizing competing risks failure time data?","volume":"12","author":"Pepe","year":"1993","journal-title":"Stat Med."},{"key":"10.1016\/j.radonc.2018.03.030_b0030","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/j.prro.2013.05.006","article-title":"Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases","volume":"4","author":"Owen","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2018.03.030_b0035","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ijrobp.2011.08.036","article-title":"Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study","volume":"83","author":"Milano","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.03.030_b0040","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ijrobp.2009.12.038","article-title":"Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases","volume":"79","author":"Greco","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.03.030_b0045","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.ijrobp.2011.02.040","article-title":"Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma","volume":"82","author":"Zelefsky","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.03.030_b0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.urolonc.2011.02.023","article-title":"Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer","volume":"31","author":"Muacevic","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.radonc.2018.03.030_b0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.clon.2015.03.006","article-title":"Initial UK experience of stereotactic body radiotherapy for extracranial oligometastases: can we change the therapeutic paradigm?","volume":"27","author":"Aitken","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2018.03.030_b0060","doi-asserted-by":"crossref","first-page":"e589","DOI":"10.1016\/j.prro.2015.05.004","article-title":"Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?","volume":"5","author":"Amini","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2018.03.030_b0065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s12885-017-3341-2","article-title":"Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)","volume":"17","author":"Habl","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2018.03.030_b0070","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.03.030_b0075","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.radonc.2007.10.017","article-title":"A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer","volume":"85","author":"Koto","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.03.030_b0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1748-717X-5-81","article-title":"Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size","volume":"5","author":"Baba","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2018.03.030_b0085","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.radonc.2014.02.002","article-title":"Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance","volume":"110","author":"Kestin","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.03.030_b0090","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1097\/JTO.0b013e318074de34","article-title":"Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study","volume":"2","author":"Onishi","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2018.03.030_b0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijrobp.2008.06.1939","article-title":"Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation","volume":"74","author":"Guckenberger","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.03.030_b0100","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1007\/s00330-011-2221-4","article-title":"Diagnosis of bone metastases: a meta-analysis comparing (1)(8)FDG PET, CT, MRI and bone scintigraphy","volume":"21","author":"Yang","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/j.radonc.2018.03.030_b0105","first-page":"0360","article-title":"The impact of MRI on gross tumor volume delineation in non-spine bony metastasis treated with stereotactic body radiation therapy","author":"Raman","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.03.030_b0110","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2018.03.030_b0115","doi-asserted-by":"crossref","first-page":"116","DOI":"10.21037\/apm.2016.03.01","article-title":"Radiological changes on CT after stereotactic body radiation therapy to non-spine bone metastases: a descriptive series","volume":"5","author":"Chiu","year":"2016","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.radonc.2018.03.030_b0120","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1016\/S1470-2045(15)00166-7","article-title":"Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group","volume":"16","author":"Thibault","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2018.03.030_b0125","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ijrobp.2015.07.2288","article-title":"Tumor response after stereotactic body radiation therapy to nonspine bone metastases: an evaluation of response criteria","volume":"93","author":"McDonald","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.03.030_b0130","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1200\/JCO.2008.19.3508","article-title":"Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases","volume":"27","author":"Rose","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.03.030_b0135","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1016\/j.ijrobp.2012.04.034","article-title":"Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors","volume":"84","author":"Cunha","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.03.030_b0140","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3171\/2015.10.SPINE141261","article-title":"Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation","volume":"24","author":"Jawad","year":"2016","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.radonc.2018.03.030_b0145","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.2013.50.1411","article-title":"Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score","volume":"31","author":"Sahgal","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.03.030_b0150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/jmrs.145","article-title":"Radiation-induced temporo-mandibular joint disorder in post-radiotherapy nasopharyngeal carcinoma patients: assessment and treatment","volume":"63","author":"Wu","year":"2016","journal-title":"J Med Radiat Sci"},{"key":"10.1016\/j.radonc.2018.03.030_b0155","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0360-3016(91)90324-W","article-title":"Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcoma","volume":"21","author":"Stinson","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.03.030_b0160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2004.12.020","article-title":"Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma","volume":"75","author":"Davis","year":"2005","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018301762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018301762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T05:59:49Z","timestamp":1531375189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814018301762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0167814018301762"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2018.03.030","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2018.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}